Comparing the frequency of anemia in rheumatoid arthritis and axial spondyloarthritis patients and its relationship with hemogram parameters
DOI:
https://doi.org/10.18203/2320-6012.ijrms20244098Keywords:
Anemia, Axial spondyloarthritis, Rheumatoid arthritisAbstract
Background: To compare the frequency of anemia in rheumatoid arthritis (RA) and radiographic axial spondyloarthritis (r-axSpA) patients and to investigate its relationship with hemogram parameters used as inflammation markers.
Methods: The study included 87 RA patients and 116 r-axSpA patients. Characteristics of the patients, hemogram parameters (neutrophil-lymphocyte ratio 'NLR', platelet-lymphocyte ratio 'PLR', systemic immune-inflammation index 'SII', red blood cell distribution width 'RDW' and mean platelet volume 'MPV'), laboratory parameters (erythrocyte sedimentation rate 'ESR' and C-reactive protein 'CRP') and indices (Disease Activity Score in 28 Joints (DAS-28) for RA and the Bath Ankylosing Spondylitis (AS) Disease Activity Index (BASDAI) and AS Disease Activity Score with CRP (ASDAS-CRP) for axSpA) were recorded.
Results: The mean age for RA and r-axSpA patients was 55.8±12.0 and 43.8±10.1 years. Anemia was present in 47.1% of RA patients and 31.9% of r-axSpA patients and more prominent in RA patients (p=0.030). There was a significant female gender superiority in those with anemia in r-axSpA patients (p<0.001). ESR, PLR, SII and RDW values were significantly higher in patients with anemia in the RA (p=0.002, p=0.048, p=0.035, p<0.001, respectively), whereas only ESR was significantly greater in patients with anemia in the r-axSpA (p=0.012). There was no significant difference between disease activity and anemia in both disease groups.
Conclusions: Although the frequency of anemia was not affected by disease activity, female gender involvement was prominent. The increase in ESR and RDW values may reflect the possibility of developing anemia in rheumatic diseases.
Metrics
References
Tanrıkulu S, Pehlevan HS, Abanonu GB, Özgür Y, Demirbaş ZE, Taycı İ, et al. The incidence of anemia and the effect of TNF-α inhibitors on anemia in patients with ankylosing spondylitis. Haydarpasa Numune Med J. 2016;56(2):104-12.
Voulgari PV, Kolios G, Papadopoulos GK, Katsaraki A, Seferiadis K, Drosos AA. Role of Cytokines in the Pathogenesis of Anemia of Chronic Disease in Rheumatoid Arthritis. Clin Immunol. 1999;v92(2): 153-60.
Kim KJ, Cho CS. Anemia of Chronic Disease in Ankylosing Spondylitis: Improvement Following Anti-TNF Therapy. Turk J Rheumatol. 2012;27(2): 90-7.
Bowman SJ. Hematological manifestations of rheumatoid arthritis. Scan J Rheumatol. 2002;31:251-9.
Swaak A. Anaemia of chronic disease in patients with rheumatoid arthritis: aspects of prevalence, outcome, diagnosis and the effect of treatment on disease activity. J Rheumatol. 2006;33:1467-8.
Abu-Zaid MH, El morsy S, Rageh EM, Shahba A, Gaber RA. The effectiveness of etanercept and adalimumab on anemia of chronic disease and serum hepcidin in patients with rheumatoid arthritis, a comparative study. Egypt Rheumatol. 2018;40(4):233-7.
Atwa ET, Omar HM, Amin A, Hammad M. Red Cell Distribution Width and Mean Platelet Volume in Rheumatoid Arthritis Patients: Its Association With Disease Activity. Reumatol Clin (Engl Ed). 2021;S1699-258X(21)00133-9.
Mercan R, Bitik B, Tufan A, Bozbulut UB, Atas N, Ozturk MA, et al. The Association Between Neutrophil/Lymphocyte Ratio and Disease Activity in Rheumatoid Arthritis and Ankylosing Spondylitis. J Clin Lab Anal. 2016;30(5):597-601.
Gökmen F, Akbal A, Reşorlu H, Gökmen E, Güven M, Aras AB, et al. Neutrophil- Lymphocyte Ratio Connected to Treatment Options and Inflammation Markers of Ankylosing Spondylitis. J Clin Lab Anal. 2015;29(4):294-8.
Asahina A, Kubo N, Umezawa Y, Honda H, Yanaba K, Nakagawa H. Neutrophil- lymphocyte ratio, platelet-lymphocyte ratio and mean platelet volume in Japanese patients with psoriasis and psoriatic arthritis: Response to therapy with biologics. J Dermatol. 2017;44(10):1112-21.
Tekeoğlu İ, Gürol G, Harman H, Karakeçe E, Çiftçi İH. Overlooked hematological markers of disease activity in rheumatoid arthritis. Int J Rheum Dis. 2016;19(11):1078-82.
Fawzy RM, Said EA, Mansour AI. Association of neutrophil to lymphocyte ratio with disease activity indices and musculoskeletal ultrasound findings in recent onset rheumatoid arthritis patients. Egypt Rheumatol. 2017;39(4):203-6.
Abd-Elazeem MI, Mohamed RA. Neutrophil-lymphocyte and platelet-lymphocyte ratios in rheumatoid arthritis patients: Relation to disease activity. Egypt Rheumatol. 2018;40(4):227-31.
Maghaddam AA, Saremi Z, Atabati E, Sharifzahed G. Hematologic parameters and disease activity in patients with primary Sjögren's syndrome. Egypt Rheumatol. 2022;44(4):329-32.
Zhong JH, Huang DH, Chen ZY. Prognostic role of systemic immune- inflammation index in solid tumors: a systematic review and meta-analysis. Oncotarget. 2017;8(43):75381-8.
Lee WS, Kim TY. Relation between red blood cell distribution width and inflammatory biomarkers in rheumatoid arthritis. Arch Pathol Lab Med. 2010;134(4):505-6.
Lin F, Wang X, Liang Y, Liu D, Zhang Y, Zhong R, et al. Red Blood Cell Distribution Width in Rheumatoid Arthritis, Ankylosing Spondylitis and Osteoarthritis: True Inflammatory Index or Effect of Anemia? Ann Clin Lab Sci. 2018;48(3):301-7.
Kisacik B, Tufan A, Kalyoncu U, Karadag O, Akdogan A, Ozturk MA, et al. Mean platelet volume (MPV) as an inflammatory marker in ankylosing spondylitis and rheumatoid arthritis. Joint Bone Spine. 2008;75(3):291-4.
Tecer D, Sezgin M, Kanık A, İncel NA, Çimen ÖB, Biçer A, et al. Can mean platelet volume and red blood cell distribution width show disease activity in rheumatoid arthritis? Biomark Med. 2016;10(9):967-74.
Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO 3rd, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 2010;62(9):2569-81.
Deodhar A. Axial spondyloarthritis criteria and modified NY criteria: issue and controversies. Clin Rheumatol. 2014;33:741–7.
van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum. 1984;27(4):361-8.
Farheen K, Agarwal SK. Assessment of disease activity and treatment outcomes in rheumatoid arthritis. J Manag Care Pharm. 2011;17:S09-13.
Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A. A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol. 1994;21(12):2286-91.
Machado P, Landewé R, Lie E, Kvien TK, Braun J, Baker D, et al. Ankylosing Spondylitis Disease Activity Score (ASDAS): defining cut-off values for disease activity states and improvement scores. Ann Rheum Dis. 2011;70(1):47-53.
Wilson A, Yu HT, Goodnough LT, Nissenson AR. Prevalence and outcomes of anemia in rheumatoid arthritis: a systematic review of the literature. Am J Med. 2004:116 Suppl7A:50S-57S.
Bes C, Yazici A, Soy M. Monoclonal anti-TNF antibodies can elevate hemoglobin level in patients with ankylosing spondylitis. Rheumatol Int. 2013;33(6):1415-8.
Önal AK, Sarıkaya S. Determination of the frequency of anemia in patients with ankylozan spondilitis and its change with biological DMARD therapy. Cukurova Med J. 2021;46(3):944-51.
McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med. 2011;365(23):2205-19.
Sieper J, Poddubnyy D. Axial spondyloarthritis. Lancet. 2017;390(10089):73-84.
Möller B, Scherer A, Förger F, Villiger PM, Finckh A; Swiss Clinical Quality Management Program for Rheumatic Diseases. Anaemia may add information to standardised disease activity assessment to predict radiographic damage in rheumatoid arthritis: a prospective cohort study. Ann Rheum Dis. 2014;73(4):691-6.
Yilmaz E. Can restless legs be a sign of something else? A case report of spondyloarthritis presenting with restless legs syndrome and review of literature. Reumatismo. 2023;75(4):190-5.
Horta-Baas G, Romero-Figueroa MDS. Clinical utility of red blood cell distribution width in inflammatory and non-inflammatory joint diseases. Int J Rheum Dis. 2019;22(1):47-54.
Tajuddin SM, Nalls MA, Zonderman AB, Evans MK. Association of red cell distribution width with all-cause and cardiovascular-specific mortality in African American and white adults: a prospective cohort study. J Transl Med. 2017;15(1):208.